Pre-Conference Add-on Session*

3:15pm-5:15pm Eastern | 2 Contact Hours

Documentation & Legal Considerations

Tony Thrasher, DO, MBA, CPE, DFAPA

Part 1: Engagement and Empathy in the Era of the Open Note: Keys to High Acuity Documentation
Part 2: EMTALA, HIPAA, and Tarasoff Oh My!: Safely Traversing the Yellow Brick Road of Healthcare Laws

*Pre-Conference Add-on is an additional fee and not included in regular registration. Access the pre-conference session through the add-on option or the One Day Thursday registration option.

Regular Conference Program

5:30pm-7:30pm Eastern | 2 Contact Hours

Keynote: Deep Dive into Medications for Schizophrenia, including Clozapine

Jonathan M. Meyer, MD, DLFAPA

Examine trends and emerging treatments to provide effective care to this population including management of side effects.

8:00am – 9:30am Eastern | 1.5 Contact Hours

Psychopharmacologic Considerations for Transgender Patients

Jose M. Cruz, DNP, APRN-CNP, PMHNP-BC

Examine interactions between gender-affirming hormone treatments and common psychotropic medications along with management of side effects and considerations for lab monitoring.

9:45am – 11:15am Eastern | 1.5 Contact Hours

Psychedelic Psychopharmacology

Craig Heacock, MD

Discover how Ketamine, psilocybin, and MDMA work in the brain and the psyche, their potential benefits and contraindications, and their interactions with the various classes of psychiatric medications.

11:15am – 1:00pm Eastern | No Contact Hours Provided

Product Theater Lunch

1:15pm – 2:15pm Eastern | 1.0 Contact Hours

Keynote: Substance Use & the Brain 

Nora Volkow, MD

Explore brain development from childhood to adulthood with emphasis on the prefrontal cortex and ADHD symptoms, impulse control, and executive functioning. Learn about the “recovering brain” and restoration of dopamine pathways when harmful substances are reduced.

2:30pm – 4:00pm Eastern | 1.5 Contact Hours

Xanax is the Only Thing that Works and Other Tales of Woe: Managing Benzodiazepines in Clinical Practice

Lydia Anne M Bartholow, DNP, PMHNP, CARN-AP

Review best practices for discussing benzodiazepines with patients from trauma informed perspective and broaden your mindset about prescribing benzos in the shadow or the opioid overdose crisis.

4:15pm – 5:45pm Eastern | 1.5 Contact Hours

Management of Agitation/Aggression/Dysregulation in the Child & Adolescent Population

Joel Stoddard, MD, MAS

6:15pm – 7:45pm Eastern | No Contact Hours Provided

Product Theater Dinner

Sponsored by Boehringer Ingelheim

8:00am – 10:00am Eastern | 1.5 Contact Hours

Deconstructing the Pharmaceutical Industry: Brand vs Generics & What It Means for Practice 

Laura G. Leahy, DrNP, APRN, PMH-CNS/FNP, CARN-AP, FAANP, FAAN

Take a deep dive into the pharmaceutical industry including how drugs get to market, how they move from brand to generic, and why it matters for prescribing practitioners.

10:15am – 11:45am Eastern | 1.5 Contact Hours

Bringing Therapy into Medication Management

Craig Heacock, MD

With a rapid med check model of practice becoming more common, learn how to restore psychotherapy into a therapeutic relationship to help increase medication efficacy.

11:45am – 1:30pm Eastern | No Contact Hours Provided

Product Theater Lunch 

Learn About COBENFY (xanomeline and trospium chloride): Where Does It Fit in Your Practice?
Don’t miss this opportunity to learn about COBENFY as a treatment option for your patients. Explore COBENFY’s clinical profile, including efficacy, safety, and dosing information. This program also highlights practical considerations when prescribing COBENFY

Amber Hoberg, PMHNP-BC
Sponsored by Bristol Meyers Squibb

1:45pm – 3:15pm Eastern | 1.5 Contact Hours

Advanced Psychopharmacology in Youth: What Works When and Why?

Jeffrey R. Strawn, MD, FAACAP

Learn thoughtful approaches to prescribing and deprescribing antidepressants for children and adolescents, including stopping medications that aren’t working, that cause intolerable side effects or are no longer needed after sustained remission.

3:30pm – 5:00pm Eastern | 1.5 Contact Hours

Geropsychiatric Prescribing Across Disorders and Settings

Kristin Hjartardottir, DNP, PMH-NP; Merrie Kaas, PhD, APRN, PMHCNS-BC, FAAN

Get age-related clinical guidelines and prescribing pearls including Lithium, antidepressants, anticholinergics and medical stability plus setting considerations.

5:30pm – 7:00pm Eastern | No Contact Hours Provided

Product Theater Dinner 

Sponsored by Boehringer Ingelheim

8:00am – 9:30am Eastern | 1.5 Contact Hours
Prescribing, Nutrition, and the Microbiome

David C. Agor, DNP, PMHNP-BC, HIVPCP

Uncover methods for improving microbiome dysbiosis with nutrients to support mental health.

9:45am – 11:15am Eastern | 1.5 Contact Hours

Acetylcholine Neurotransmission, Muscarinic Receptors, and Anticholinergic Burden: Implications for Schizophrenia Spectrum Disorders

Jeremy Mills, DNP, PMHNP-BC

With the advent of novel antipsychotic medications modulating acetylcholine, gain crucial understanding of muscarinic activity and learn about anticholinergic side effects.

11:15am – 1:00pm Eastern | 1 Contact Hour

Symposium Lunch

Depression in Focus: Addressing Residual Symptoms for Functional Recovery

1:15pm – 2:45pm Eastern | 1.5 Contact Hours

General Psychiatric Management: Principles and Prescribing Guidelines for Treating Borderline Personality Disorder 

Jeffrey Lucero, MSN, RN, PMHNP-BC

Explore GPM, an evidence based model for BPD treatment with a focus on guidelines for psychiatric prescribing.